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ABSTRACT 
 
A cGMP signaling pathway, comprising C-type natriuretic peptide (CNP), its guanylate cyclase 
receptor Npr2, and cGMP-dependent protein kinase I (cGKI), is critical for the bifurcation of 
dorsal root ganglion (DRG) and cranial sensory ganglion axons when entering the mouse spinal 
cord and the hindbrain, respectively. However, the identity and functional relevance of 
phosphodiesterases (PDEs) that degrade cGMP in DRG neurons are not completely understood. 
Here we asked whether regulation of the intracellular cGMP concentration by PDEs modulates 
the branching of sensory axons. Real-time imaging of cGMP with a genetically encoded 
fluorescent cGMP sensor, RT-PCR screens, in situ hybridization, and immunohistology 
combined with the analysis of mutant mice identified PDE2A as the major enzyme for the 
degradation of CNP-induced cGMP in embryonic DRG neurons. Tracking of PDE2A-deficient 
DRG sensory axons in conjunction with cGMP measurements indicated that axon bifurcation 
tolerates increased cGMP concentrations. Since we found that the natriuretic peptide scavenger 
receptor Npr3 is expressed by cells associated with dorsal roots but not in DRG neurons itself at 
early developmental stages, we analyzed axonal branching in the absence of Npr3. In Npr3-
deficient mice, the majority of sensory axons showed normal bifurcation, but a small population 
of axons (13%) was unable to form T-like branches and generated turns in rostral or caudal 
directions only. Taken together, this study shows that sensory axon bifurcation is insensitive to 
increases of CNP-induced cGMP levels and Npr3 does not have an important scavenging 
function in this axonal system. 
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INTRODUCTION 
 
cGMP is an ubiquitous second messenger involved in a multitude of cellular functions (Kemp-
Harper & Feil, 2008). cGMP is synthesized from GTP by heterodimeric NO-sensitive soluble 
guanylate cyclases or homodimeric transmembrane guanylate cyclases such as Npr2 (Kuhn, 
2016). Genetic studies showed that the CNP/Npr2/cGMP pathway regulates endochondral bone 
growth (Peake et al. 2014; Potter 2011b), sensory axon bifurcation (Gibson & Ma 2011; Schmidt 
& Rathjen 2010), and meiotic prophase arrest during oocyte maturation (Shuhaibar et al. 2015; 
Zhang et al. 2010). In humans, biallelic loss-of-function mutations in the Npr2 gene result in 
acromesomelic dysplasia type Maroteaux (AMDM), a skeletal dysplasia with an extremely short 
and disproportionate stature (Bartels et al. 2004).  
Sensory axons from DRGs or cranial ganglia enter the spinal cord or hindbrain, respectively, 
dorsally and then immediately form a T-like branch. The two stem axons that evolve from the 
splitting of the growth cone extend over several segments along the lateral margin of the cord or 
hindbrain. In the absence of the ligand CNP or the receptor Npr2, sensory axons no longer form 
T-like branches and instead grow only in either rostral or caudal direction (Schmidt et al. 2009; 
Schmidt et al. 2007; Ter-Avetisyan et al. 2014; Zhao & Ma 2009). Identical branching defects 
were observed in mutants that lack cGKI indicating that cGKI is the downstream effector of the 
CNP/Npr2/cGMP pathway (Schmidt et al. 2002). Interestingly, studies on human body height 
regulation indicated that not only complete loss-of-function mutations but also mutations that 
lead to variations of the CNP level or Npr2 activity can affect skeletal growth (Estrada et al. 
2009; Olney et al. 2012; Potter 2011b). Therefore, it is of interest to clarify whether 
deregulations of cGMP levels also affect axonal bifurcation within the spinal cord. Branching 
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errors of even a subpopulation of sensory axons in the spinal cord might affect sensory 
perception. 
cGMP homeostasis is controlled by the rate of its synthesis via guanylate cyclases and 
degradation via PDEs (Bender & Beavo 2006; Maurice et al. 2014; Xu et al. 2011). Hydrolysis 
of cyclic nucleotides by PDEs might prevent the diffusion of cyclic nucleotide signals into 
neighboring intracellular compartments and, therefore, contribute to the fine-tuning of cGMP 
signaling. 
cGMP signaling is also regulated by the availability of natriuretic peptides in the extracellular 
milieu, which is dependent on the scavenger receptor Npr3. In chondrocytes, it acts as a 
clearance receptor by subjecting natriuretic peptides to lysosomal degradation. Deletion of Npr3 
in mice results in significant skeletal overgrowth (Matsukawa et al. 1999). Therefore, Npr3 
might also modulate CNP/Npr2 signaling in DRG neurons. 
In the present study, we asked which of the known PDEs hydrolyzes CNP/Npr2-induced cGMP 
in sensory neurons and whether a deficit of cGMP degradation affects branching of sensory 
axons. Our studies indicate that PDE2A is important for the hydrolysis of cGMP in embryonic 
DRGs, that Npr2-mediated axon bifurcation tolerates increased cGMP levels in the absence of 
PDE2A, and that a subpopulation of sensory axons fails to bifurcate in the absence of the 
scavenger receptor Npr3.  
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Materials and methods 
FRET-based cGMP imaging in DRG neurons 
 
DRG neurons were isolated from R26-CAG-cGi500(L1) mice that express the cGMP sensor 
cGi500 globally in all tissues (Thunemann et al. 2013b). C57BL/6 female mice were mated with 
R26-CAG-cGi500 heterozygous male mice. Plug-positive females were separated 0.5 dpc. At 
day 12.5 dpc pregnant females were euthanized with CO2 and cGi500 transgenic embryos were 
used for further preparation. The spinal cord with attached DRGs was dissected from E12.5 
embryos and 30-40 DRGs were collected. The DRGs were trypsinized, suspended in 
DMEM/F12 (Invitrogen) supplemented with 10% horse serum (Life Technologies), 0.3 mg/mL 
L-glutamine (Life Technologies), 1% penicillin/streptomycin (Invitrogen), 8 mg/mL glucose 
(Roth), and 100 ng/mL nerve growth factor (Alomone Labs), and plated on poly-D-
lysine/laminin-coated coverslips. Cells were grown at 37°C and 6% CO2 in a humidified 
incubator. 
FRET/cGMP imaging was performed 24 hours after plating using an imaging setup as described 
previously (Thunemann et al. 2013a; Thunemann et al. 2013b). Briefly, the imaging setup was 
based on an inverted Axiovert 200 microscope (Carl Zeiss Microscopy GmbH) equipped with a 
Plan NeoFluar40×/1.30 oil objective, a light source with excitation filter switching device 
(Oligochrome, TILL Photonics GmbH), a DualView beam splitter with 516 nm dichroic mirror 
and emission filters for CFP (480/30 nm) and YFP (535/40 nm) (Photometrics), and a charge-
coupled device camera (Retiga 2000R, QImaging). The cells were superfused at room 
temperature at a flow rate of 1 mL/min with imaging buffer (in mM: NaCl 140, KCl 5, MgSO4 
1.2, CaCl2 2.5, glucose 5, HEPES 5, pH 7.4) without drugs or with ANP (Tocris), Bay 60-7550 
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(Santa Cruz), BNP (Phoenix Pharmaceuticals), CNP (Tocris), DEA/NO (Axxora), EHNA 
(Axxora), IBMX (Sigma Aldrich), milrinone (Santa Cruz), sildenafil (Santa Cruz), vinpocetine 
(Biomol), or zaprinast (Santa Cruz). For the analysis of FRET data, ImageJ (Schneider et al. 
2012), Microsoft Excel (Microsoft Corp.), and OriginPro (OriginLab Corp.) software were used. 
F480 and F535 traces were background-corrected before calculating the F480/F535 ratio R. 
∆F480/F480, ∆F535/F535 and ∆R/R traces were obtained by normalization to the baseline recorded 
for 2-3 min at the beginning of each experiment (Thunemann et al. 2013a). For ∆R/R peak area 
calculation, the OriginPro peak area analyzer was used. The peak borders were defined manually. 
 
Statistical analysis 
 
For statistical analysis of PDE inhibitor studies with triple CNP stimulation, a one-way ANOVA 
was performed for repeated measurements using OriginPro 2015G Software (OriginLab 
Corporation, Northampton, MA, USA). Results are shown as average of peak area ± SEM. To 
test for homogeneity of variance the Levene’s test was used. Significance testing was carried out 
using Bonferroni post-hoc test to compare the three individual CNP stimulations. P values ˂0.05 
were considered to be significant. T-test was applied for the pairwise comparison of cGMP 
concentrations in intact DRGs and for the analysis of axon bifurcation in the absence of PDE2A 
or Npr3. 
 
cGMP concentrations in intact DRGs 
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cGMP concentrations in acutely isolated DRGs from wild type or PDE2A-deficient embryos 
were measured after or without stimulation with 0.5 µM CNP-22 (Calbiochem) by the cGMP 
Biotrak assay from GE Healthcare as detailed in (Schmidt et al. 2009).  
 
Mice  
 
The following mutant mice were used: R26-CAG-cGi500(L1) (Gt(ROSA)26Sor
tm1.1(CAG-
ECFP/EYFP*)
/
Feil
) (Thunemann et al. 2013b), Npr2-lacZ (B6.129P2-Npr2
tm1.1(nlsLacZ)
/
Fgr
 (Ter-
Avetisyan et al. 2014), PDE2A knockout (B6;129P2-Pde2a
tm1Dgen
/
H
, obtained from EMMA), 
Npr3 knockout (B6;129-Npr3
tm1Unc
/
Mmnc
 obtained from MMRRC) (Matsukawa et al. 1999), and 
Thy1-GFP-M (Tg(Thy1-EGFP)MJrs) (Feng et al. 2000). Littermates served as controls. The 
animal procedures were performed according to the guidelines from directive 2010/63/EU of the 
European Parliament on the protection of animals used for scientific purposes. All experiments 
were approved by the local authorities of Berlin (LAGeSo Berlin licence numbers T0313/97 and 
G0371/13). For FRET-based cGMP imaging studies four C57BL/6 female mice (age 12-24 
weeks) were euthanized using CO2 and for histological studies mice were sacrificed by cervical 
dislocation and embryos by decapitation. In total, six cGi500 transgenic embryos were used for 
E12.5 DRG preparation. For the histology in total six adult females and their embryos at E12.5, 
for binding experiments using AP-CNP-53 two Npr3 heterozygous females and their embryos at 
E12.5, for cGMP determination eight wild type and three PDE2A heterozygous females with 
their embryos at E13.5, for bifurcation studies three PDE2A heterozygous females and their 
embryos at E12.5 and eight Npr3 and three wild type mice and for the RT-PCR studies one 
female with E12.5 embryos were used. 
European Journal of Neuroscience
8 
 
 
Immunohistology, expression of a CNP-53 fusion protein, and axon tracing 
 
Paraformaldehyde-fixed cryostat sections (15-µm thick) were stained with the following 
antibodies: rabbit anti-PDE2A (Santa Cruz, SC-25565, 1:150), rabbit anti-cGKI  (Valtcheva et 
al. 2009) (1:1000), chick anti-beta-galactosidase (Abcam, ab9361, 1:5000), rabbit anti-alkaline 
phosphatase (GenHunter Corp., Q301, 1:2500) or mAb anti-neurofilament (2H3, Developmental 
Hybridoma Bank, 7.5 µg/ml). Secondary antibodies were applied at the following dilutions: 
1:1,000 goat-anti-chick-IgY-Alexa647, 1:1,000 goat-anti-rabbit-Cy3, 1:1,000 goat-anti-rabbit-
Alexa647, 1:1,000 goat-anti-mouse-Alexa647 (Dianova). 
All microscopic images were obtained at room temperature using either an Axiovert 135 inverted 
microscope equipped with Neofluar/Acroplan objectives (5x, 10x, or 40x magnification with 
numerical apertures 0.15, 0.25, or 0.75, respectively), a charge-coupled device camera (Axiocam 
HRC), and acquisition software (Axiovision 3.1) or by confocal imaging using an Axio 
Observer.Z1 inverted microscope equipped with ZEN 2011 software and the following lenses: a 
Plan-Neofluar 10x/0.30 NA objective or a Plan-Achromat 63x/1.40 NA oil objective (all from 
Carl Zeiss MicroImaging, GmbH). Images were imported into Photoshop CS5 (Adobe) for 
adjustment of contrast and brightness. Figures were assembled using Illustrator CS5 (Adobe).  
As an affinity probe for CNP receptors a chimeric protein termed AP-CNP-53 was produced that 
consists of the 53 C-terminal amino acid residues of CNP fused at its N-terminus to secreted 
alkaline phosphatase. The DNA sequence that includes the ORF of CNP was amplified from an 
E17 whole mouse embryo cDNA library using primers Nppc-Forward and -Reverse (Table S1) 
and subsequently subcloned into the EcoRV-site of pBluescript II KS (Stratagene). From the 
resulting plasmid a sequence encoding the 53 C-terminal amino acids of CNP was reamplified 
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using primers AP-CNP-53 and T3 (Table S1), digested with XhoI, and introduced into the XhoI-
site of the pAPtag-5 expression vector (GenHunter Corp.). Expression of AP-CNP-53 in 
transiently transfected COS7 cells was confirmed by immunoblotting of the supernatant with the 
following antibodies: rabbit anti-CNP (Peninsula Laboratories Inc., T-4223) and rabbit anti-
alkaline phosphatase (GenHunter Corp., Q301). Supernatants were directly applied to 
paraformaldehyde-fixed spinal cords from E12.5 mouse embryos for 1 hour and binding was 
visualized by the alkaline phosphatase reaction using the substrates 5-Bromo-4-chloro-3-indolyl 
phosphate (BCIP) and nitro blue tetrazolium chloride (NBT) (Sigma) according to the protocol 
by Brennan and Fabes (Brennan & Fabes 2003).  
Bifurcation of sensory axons was analyzed by DiI injections or by the reporter mouse Thy-1-
GFP-M as detailed elsewhere (Feng et al. 2000; Schmidt & Rathjen 2011; Schmidt et al. 2007). 
 
RT-PCR and in situ hybridization 
 
RNA from E12.5 mouse DRG was isolated using TRI Reagent (Sigma) according to the 
manufacturer’s instructions. cDNA was synthetized using SuperScript III (Thermo Fisher 
Scientific). PCR was performed using primers as detailed in table S1 of the supporting 
information. An E17 whole mouse embryo cDNA library served as a positive control.  
For in situ hybridization DNA fragments encoding Pde2A, cGKI and Npr3 were amplified using 
primers PDE2A-FOR and –REV, Prkg1-FOR and –REV and Npr3-FOR and -REV, respectively, 
and subcloned into the EcoRV-site of pBluescript II KS (Stratagene) to serve as template for the 
generation of sense and anti-sense probes. Mouse embryos at E11.5, E12.5 and E13.5 were 
freshly embedded into OCT compound (Sakura Finetek USA Inc.) and 25 µm transversal 
sections were processed as previously described (Schmidt et al. 2007). 
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RESULTS 
 
PDE2A degrades cGMP in embryonic DRG neurons 
 
To analyze cGMP levels, real-time imaging experiments were performed by fluorescence 
resonance energy transfer (FRET) measurements in DRG neurons obtained from transgenic mice 
that express the genetically encoded FRET-based cGMP sensor, cGi500 (Russwurm et al. 2007; 
Thunemann et al. 2013b). DRG neurons from E12.5 embryos were cultivated on laminin1 at low 
density allowing for the analysis of individual neurons. The cGMP sensor is found to be 
localized uniformly throughout the neuron including the axon shaft and growth cone (Fig. 1A 
and C). Since recordings made at the growth cone were less intense the following FRET 
measurements and quantifications were performed at the cell soma (Fig. 1B and D). Upon 
application of 100 nM CNP, but not ANP, BNP or the NO donor DEA/NO, the intracellular 
cGMP level was increased immediately (Fig. 1D), which is in line with our previous studies on 
intact embryonic DRGs from CNP mutant or wild type mice and which is also in agreement with 
the pattern of expression of guanylate cyclases in embryonic DRGs (Schmidt et al. 2009; 
Schmidt et al. 2007). After removal of CNP, the cGMP level decreased within five minutes to 
baseline (Fig. 1C and D) suggesting that intracellular cGMP is quickly degraded to GMP by 
PDEs in DRG neurons. Indeed, the broad-spectrum PDE inhibitor IBMX (100 µM) significantly 
enhanced CNP-induced cGMP accumulation as compared to CNP alone (Fig. 1E to G).  
To analyze the expression of PDEs in embryonic DRG and spinal cord neurons, RT-PCR was 
performed focusing on known PDEs which specifically hydrolyze cGMP or which are dual 
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substrate enzymes and degrade both cAMP and cGMP (in total 16 enzymes) (Xu et al. 2011). 
RT-PCR revealed expression of mRNAs of PDE2A, 3A, 3B, 6D, 6G, 9A, 10A, and 11A but not 
of PDE1A, 1B, 1C, 5A, 6A, 6B, 6C and 6H in embryonic DRGs (Fig. 2). Except for 6A, 6B, 6C 
and 6H, all tested PDEs were also found in embryonic spinal cord.  
Real-time cGMP imaging was used to identify functionally relevant PDEs, which degrade CNP-
induced cGMP in DRG neurons. A set of six blockers (Maurice et al. 2014) of PDEs, whose 
mRNAs were detected in DRGs by RT-PCR, was applied before stimulation of DRG neurons 
with CNP. The PDE blockers alone did not affect the intracellular concentration of cGMP in 
DRG neurons (see Fig. S1). FRET microscopy showed that CNP-induced cGMP was increased 
by the PDE2 inhibitors EHNA and Bay 60-7550, while blockers of PDE1 (vinpocetine), PDE3 
(milrinone), PDE5 (sildenafil), and PDE5, 6, 9, 10, 11 (zaprinast) did not affect the level of 
intracellular cGMP (Fig. 3A to F, see also Fig. S1, S2 and table S2). 
Next, we measured cGMP levels by an ELISA-based method in DRG extracts prepared from 
wild type and PDE2A-deficient mice (Fig. 4). In wild type DRGs, we detected with this method a 
strong cGMP increase upon CNP stimulation when simultaneously the PDE blocker IBMX was 
applied. In the absence of PDE2A, however, CNP-induced cGMP increases were clearly 
detectable without blocking PDEs with IBMX. The basal level of cGMP in PDE2A -/- 
embryonic DRGs is indistinguishable from the wild type situation (Fig. S3). Taken together, our 
pharmacological and genetic evidence indicated that PDE2A is the major PDE involved in the 
hydrolysis of CNP-induced cGMP in embryonic DRG neurons and that other PDEs are not able 
to fully compensate for lacking PDE2A activity. 
 
PDE2A is expressed by embryonic DRG neurons  
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In situ hybridizations revealed a strong expression of PDE2A mRNA in neurons of DRGs and 
weak expression in a ventrally localized population of cells in the spinal cord similar to the 
localization of Npr2 or cGKI mRNA at these stages – two known components implicated in T-
branch formation (Fig. 5A and 5E, compare A and E) (Schmidt et al. 2007; Schmidt et al. 2002). 
Consistently, immunofluorescence staining of transversal cryostat sections of early embryonic 
stages, when sensory axons are entering the spinal cord, showed localization of PDE2A in DRG 
neurons, in the dorsal root and in the dorsal funiculus – a structure which contains DRG axons 
within the spinal cord – and in a ventrally localized population of the spinal cord (Fig. 5B, 
compare B and F). Higher magnifications of stained cryostat sections of DRGs showed 
localization of PDE2A in DRG neurons that also express Npr2 (Fig. 5G) and cGKI (Fig. 5E and 
F). Within the spinal cord, PDE2A expression was observed in a ventrally localized pool of cells, 
most likely motoneurons, while other spinal cord cells appeared to be negative for PDE2A (Fig. 
5A and B). Overall, this timing and pattern of expression of PDE2A in the somata of DRGs, their 
axons and spinal cord is very similar to that observed for cGKI and Npr2 at embryonic stages 
(Schmidt et al. 2009; Schmidt et al. 2007; Schmidt et al. 2002). This localization is also in 
accordance with hydrolysis of Npr2-generated cGMP by PDE2A.  
Three isoforms of PDE2A - PDE2A1, PDE2A2 and PDE2A3 - are encoded by mRNAs with 
different 5’-regions that result in different amino-terminal regions. Further inclusion of a 62 bp or 
a 12 bp insert in the 5’- or central region, respectively, results in additional isoforms of PDE2A 
(see scheme in Fig. 5D). RT-PCR analysis revealed that PDE2A1, PDE2A2 and transcript 
variant 1 (isoform 6) of PDE2A are expressed in both the embryonic spinal cord and DRGs while 
PDE2A3 is only faintly expressed in DRGs whereas transcript variant 5 (isoform 5) of PDE2A 
was undetectable in both tissues (Fig. 5C). PDE2A1 is a soluble form, while PDE2A2 and 
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PDE2A3 are associated with membranes (Acin-Perez et al. 2011; Russwurm et al. 2009) 
suggesting that PDE2A is found in different subcellular compartments of DRG neurons. 
 
Genetic deletion of PDE2A does not affect bifurcation of sensory axons 
 
On the basis of the localization of PDE2A in embryonic DRGs and its involvement in cGMP 
hydrolysis upon CNP/Npr2 stimulation we investigated branching of sensory axons in the spinal 
cord in the above mentioned mouse strain deficient for PDE2A. PDE2A-deficient mice do not 
survive to weaning age for unknown reasons 
(www.infrafrontier.eu/sites/infrafrontier.eu/files/upload/public/deltagen/DELTAGEN_T1165/). 
However, the overall structure of the nervous system is not affected by the absence of PDE2A at 
early developmental stages (see, for example, cross sections of the spinal cord stained by an 
antibody to neurofilament in Fig. 6A). Analysis of T-branching by DiI tracing at embryonic day 
12.5 demonstrated that PDE2A knockout mouse mutants did not reveal branching errors (Fig. 
6B). DRG axons showed normal T-like bifurcations and did not form multiple branches in the 
dorsal root entry zone. Sensory axons extended at lateral regions of the spinal cord as in wild 
type spinal cords (Fig. 6A) suggesting that the process of bifurcation and extension can tolerate 
the lack of cGMP degradation by PDE2A. 
 
Role of the scavenger receptor Npr3 in axonal bifurcation 
 
CNP is thought to be cleared from the extracellular space by the scavenger receptor Npr3 (also 
termed NPR-C), which in turn might affect cGMP levels. Consistently, loss-of-function 
mutations of Npr3 cause skeletal overgrowth in rodents due to increased levels of CNP in the 
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extracellular space (Jaubert et al. 1999; Matsukawa et al. 1999). In situ hybridization revealed 
expression of Npr3 mRNA in the roof and floor plate of the spinal cord and along the dorsal 
roots at E12.5 (Fig. 7A), while DRG were negative for Npr3, which is consistent with previously 
published data (Zhao & Ma 2009). The expression of Npr3 mRNA in the dorsal roots suggests 
that Schwann cells or their precursors may express Npr3.  
Due to a lack of appropriate antibodies that bind to Npr3 in intact tissues a fusion protein, AP-
CNP-53 (Fig. 7B), composed of alkaline phosphatase and CNP-53, a proteolytically processed 
form of CNP, was generated to study the localization of Npr3 protein. This fusion protein binds 
strongly to Npr3 expressed in heterologous cells whereas binding to Npr2 was below the 
detection limit in this assay (Fig. S4). In a whole mount preparation of the intact embryonic 
spinal cord AP-CNP-53 bound to the dorsal roots as well as the roof and floor plate but not to the 
attached DRGs from wild type mice (Fig. 7C). Only weak or no binding was observed in the 
dorsal funiculus. The signal was strongly decreased in tissue from Npr3-deficient mice indicating 
that AP-CNP-53 binding primarily reflected the localization of the Npr3 protein in the dorsal root 
and roof plate. The lack of binding in the dorsal funiculus of the Npr3 mutant also indicated that 
this fusion protein binds not or only weakly to Npr2 as also demonstrated for transfected COS7 
cells in Fig. S3 of the supporting information. Npr2 is localized in the dorsal funiculus, dorsal 
root and somata of the DRG neurons (Schmidt et al. 2007). Previous studies also indicated high-
affinity binding of CNP to Npr3 (Waldman et al. 2008). This pattern of expression of Npr3 in the 
dorsal roots prompted us to trace the branching of sensory axons at the dorsal root entry zone. 
Despite its strong expression in the dorsal root, the absence of Npr3 did not result in the 
formation of accessory branches as might be anticipated from its role in the skeletal system 
where Npr3 acts as scavenger receptor. In contrast, analysis of axonal branching using the 
reporter mouse Thy1-GFP-M indicated that the majority of axons bifurcate normally in Npr3 
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knockout mice. Furthermore, no ectopic T-branching was observed in the dorsal roots (Fig. 7D) 
which might have been assumed in the absence of CNP clearance by the lacking Npr3 in the 
dorsal roots. Interestingly, a small percentage of axons (13%) was found at all trunk levels not to 
branch and to turn only in rostral or caudal direction in the absence of Npr3 (Fig. 7D and E). 
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DISCUSSION 
 
Our cGMP imaging experiments in individual live cells showed that cGMP generation in 
embryonic DRG neurons is stimulated by CNP but not by ANP, BNP or NO which is consistent 
with our previously published data on the pattern of expression of guanylate cyclases in 
embryonic DRGs. These findings complement our previous investigations on the CNP/Npr2 
signaling system, which showed an essential role of cGMP signaling for the bifurcation of 
sensory axons. In the absence of CNP, Npr2 or cGKI, sensory axons are unable to form T-like 
branches when entering the spinal cord or hindbrain (Schmidt & Rathjen 2010; Schmidt et al. 
2009; Schmidt et al. 2007; Ter-Avetisyan et al. 2014; Zhao & Ma 2009). Most likely, T-
branching is required for a refined and precise representation of the body within the central 
nervous system. Our real-time imaging experiments also demonstrated that CNP-induced cGMP 
is hydrolyzed within minutes in embryonic DRG neurons. Although several PDEs are detected at 
the level of mRNAs in embryonic DRGs, our pharmacological and genetic analyses indicated 
that PDE2A is the most relevant enzyme to degrade CNP-induced cGMP in DRG neurons. 
Accordingly, after application of CNP cGMP levels increased in intact PDE2A-deficient DRGs 
in the absence of PDE blockers. However, compensatory mechanisms, e.g. upregulation of other 
PDEs in sensory neurons, cannot be fully excluded to prevent more drastic increases of cGMP 
levels in the absence of PDE2A. The normal function of cGMP-specific PDEs is to keep cGMP 
levels in a narrow range of concentrations, which might be essential for restricted activation of 
cGMP-dependent effector proteins. To our surprise, impaired degradation of cGMP and, hence, 
increased CNP-induced cGMP concentrations in the absence of PDE2A did not disturb T-
branching of sensory axons, for example, by repeated T-like branching at the dorsal root entry 
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zone or by affecting overall pathfinding of the growth cone. It appears that sensory axon 
bifurcation and extension tolerates an increased intracellular cGMP level upon CNP stimulation. 
Up to now, only loss-of-function mutations of cGMP pathway components in DRG neurons have 
been shown to cause defects in sensory axon bifurcation. This is remarkable since increasing 
levels of CNP or Npr2 activity have been reported to affect human body height. For example, 
heterozygous gain-of-function mutations of Npr2 (Hannema et al. 2013; Miura et al. 2012; 
Robinson et al. 2013) or balanced translocations in chromosome 2 near the locus of the Nppc 
gene, resulting in overproduction of CNP, cause a tall stature in humans (Bocciardi et al. 2007; 
Moncla et al. 2007).  
Overall, it might be speculated that an immediate degradation of cGMP in DRGs by PDE2A in 
the wild type might be required to prevent a spreading of cGMP generated by Npr2 to other 
cGMP-dependent signaling systems in other cellular compartments. A fast degradation might be 
important to maintain compartmentalization of cGMP-dependent signaling events. PDE2A 
hydrolyzes cGMP and cAMP with approximately equal efficiency allowing a negative crosstalk 
on intracellular cAMP signaling pathways (Zaccolo & Movsesian 2007). It is generally thought 
that cGMP and cAMP signaling pathways are connected in a complex network including a 
precise spatial organization, and cGMP regulates cAMP signaling by activating or inhibiting 
cAMP-degrading PDEs (Zaccolo & Movsesian 2007). Previous in vitro experiments using 
organotypic slice cultures or growth cone turning assays revealed a link between cAMP and 
cGMP signaling in growth cone extension and steering (Heine et al. 2013; Song et al. 1998; 
Tojima et al. 2011). Our results show that PDE2A-mediated cyclic nucleotide crosstalk is not 
required for sensory axons to branch or to grow correctly into the spinal cord in vivo. 
At more advanced developmental stages, PDE2A expression has a widespread distribution in the 
central nervous system including the limbic system, olfactory cortex, amygdala and hippocampus 
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(Van Staveren et al. 2003). Our study does not exclude roles of PDE2 in brain functions such as 
memory formation, inflammatory pain processing, and synaptic plasticity (Fernandez-Fernandez 
et al. 2015; Hu et al. 2012; Kallenborn-Gerhardt et al. 2014; Redrobe et al. 2014; Zhang et al. 
2015). 
Our studies with Npr3-deficient mice further support the notion that bifurcation of sensory axons 
at the dorsal root entry zone is not disturbed by elevated cGMP levels. In regard to the skeletal 
system, absence of the scavenger receptor Npr3 causes skeletal overgrowth by increased 
endochondral ossification due to a reduced clearance of CNP from the extracellular milieu 
through Npr3 receptor-mediated internalization (Jaubert et al. 1999; Matsukawa et al. 1999). 
Thus, in Npr3-deficient mice one might expect an increase of the extracellular CNP 
concentration in the dorsal spinal cord or dorsal roots leading to a higher number of T-branches 
or ectopic branching already in the dorsal root before axons are entering the spinal cord. 
However, contrary to our expectations, genetic deletion of Npr3 led to an impairment of T-
branching in only a small fraction of 13% of sensory axons. Apparently, the potential scavenger 
function of Npr3 for CNP is not functionally relevant for the majority of sensory axons in dorsal 
roots. Specifically, absence of Npr3 does not impair CNP/Npr2 signaling in these axons when 
forming T-branches at the dorsal root entry zone. As discussed by others (Potter et al. 2006), 
Npr3, which lacks an intracellular guanylate cyclase domain, might also have a signaling 
function that is currently unknown for dorsal root cells. The absence of Npr3 expression in DRG 
axons and its expression only in cells of the dorsal root at early developmental stages suggests 
that, in contrast to chondrocytes, Npr3 is not directly linked to the CNP/Npr2 signaling system in 
the DRG neurons. The reasons for the deficits in axon branching in 13% of the sensory neurons 
in Npr3-deficient mice are currently unknown but might have a secondary origin associated with 
the overall overgrowth defects of this mutant (Matsukawa et al. 1999).  
European Journal of Neuroscience
19 
 
In summary our investigations on the system of axonal T-branching indicate that PDE2A is 
essential for efficient hydrolysis of cGMP in embryonic DRG neurons, that variations in cGMP 
levels caused by the absence of PDE2A do not interfere with proper axon bifurcation, and that 
the influence of the scavenger receptor Npr3 on sensory axon bifurcation is limited to a minor 
degree. Since bifurcation apparently tolerates high cGMP concentrations, it is unlikely that 
human patients with variations of PDE2A activity show bifurcation errors of sensory axons. 
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Figure Legends 
 
Figure 1 
 
FRET-based cGMP imaging in individual DRG neurons from R26-CAG-cGi500 (L1) 
mice.  
 
 (A) Representative image of an E12.5 DRG growth cone expressing the cGMP sensor 
cGi500 (shown in green). A DRG explant culture was prepared to test the CNP stimulus on 
DRG growth cones. DRGs from R26-CAG-cGi500(L1) were isolated (see materials and 
methods), cut in half and transferred to the culture dish. Scale bar 10 µm. (B) Measurements 
were started 24 h after plating. FRET-based cGMP imaging was performed with perfusion of 
100 nM CNP (black horizontal bar). Signals were recorded from the growth cone. Traces 
indicate CFP emission (F480), YFP emission (F535), and the CFP/YFP emission ratio 
(R=F480/F535). Emission intensities and ratios were normalized to averaged baseline signals 
and are given as ∆F/F and ∆R/R, respectively. (C) Expression of the cGi500 biosensor in a 
DRG neuron cultivated in a monolayer  from E12.5 embryos 24 hours after plating. Scale bar, 
20 µm. (D) FRET-based cGMP imaging was performed with perfusion of drugs (horizontal 
bars) in the following order: 100 nM DEA/NO, 100 nM ANP, 100 nM BNP, and 100 nM 
CNP. Signals were recorded from the soma. Traces indicate CFP emission (F480), YFP 
emission (F535), and the CFP/YFP emission ratio (R=F480/F535). Emission intensities and 
ratios were normalized to averaged baseline signals and are given as ∆F/F and ∆R/R, 
respectively. Note that changes of ∆R/R indicate changes of the intracellular cGMP 
concentration. Based on in-cell calibration of cGi500 in permeabilized vascular smooth 
muscle cells (Thunemann et al. 2013a), the peak of the CNP-induced cGMP transient in 
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E12.5 DRG neurons corresponds to ~0.5 µM cGMP. Representative results from ≥ 3 
experiments with independent cell cultures are shown. 
(E-G) The broad-spectrum PDE inhibitor IBMX potentiates the CNP-induced cGMP signal in 
DRG neurons. (E and F) FRET-based cGMP imaging was performed in cells that were 
superfused three times with 100 nM CNP (black horizontal bars in panel F), with the second 
CNP application in presence of 100 µM IBMX (red horizontal bar in panel F). Signals were 
recorded from the soma. Changes of ∆R/R reflect changes of the intracellular cGMP 
concentration. The signals at time points t0-t3 indicated in panel F correspond to the pictures 
shown in panel E. (F) Compared to baseline (t0), stimulation with 100 nM CNP (t1) leads to 
an elevation of the CFP/YFP emission ratio (R=F480/F535) that correlates with the 
intracellular cGMP concentration. After preincubation with IBMX, CNP stimulation (t2) 
results in ~2.5 times higher peak cGMP concentrations as compared to CNP alone. After 
washout of IBMX, the third CNP application (t3) leads to an increase of the cGMP 
concentration that is comparable to the first stimulation. Scale bar, 20 µm. (G) Summary of 
CNP-induced cGMP signals before, during and after incubation with IBMX. Peak areas were 
taken as a measure of the cGMP response and normalized to the first peak of the experiment. 
Data are mean±SEM (n = 6 cells); ***p˂0.001. 
 
Figure 2 
 
Several PDEs are expressed in embryonic DRGs and spinal cord. 
 
(A and B) RT-PCR screen of cGMP-specific and dual substrate-specific PDEs expressed in 
E12.5 DRGs or spinal cord (SC). For comparison amplification products of Npr2 and cGKIα 
are shown in A). The sizes of the PCR amplification products are given in parenthesis. – no 
template in the reaction mixture, + amplification from an embryonic mouse cDNA library. 
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Figure 3 
 
Pharmacological profiling of PDE activities in DRG neurons.  
 
FRET-based cGMP imaging was used to determine the effects of various PDE inhibitors on 
CNP-induced cGMP signals as described in the legend to Figure 1. Cells were stimulated 
three times with 100 nM CNP. The second CNP stimulation was done after preincubation of 
the cells for 5 min with (A) 5µM vinpocetine (Vin), (B) 10 nM Bay 60-7550 (Bay), (C) 10 
µM EHNA, 10 µM milrinone (Mil), (E) 20 µM sildenafil (Sil), or (F) 20 µM zaprinast (Zap). 
The specificity of each PDE inhibitor is indicated above each diagram. Signals were recorded 
from the soma. Peak areas were taken as a measure of the cGMP response and normalized to 
the first peak of each experiment. Data are mean±SEM (n cells in the experiment as indicated 
in the respective panel at the right); ***p˂0.001; *p˂0.05. 
 
Figure 4 
 
PDE2A degrades CNP-induced cGMP. 
 
Intact DRGs from wild type, PDE2A heterozygote or homozygous knockout mice were 
incubated with or without CNP-22 (0.5 µM) for 15 minutes at 37
o
C in the presence or 
absence of IBMX (1 mM). The cGMP concentration in DRG extracts was determined by an 
ELISA-based method as described in (Schmidt et al. 2009).  Values are mean±SEM; numbers 
above columns indicate numbers of independent DRG preparations; t-tests were performed to 
compare the mean difference of two groups;*** p<0.001, n.s., non-significant. 
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Figure 5 
 
Analysis of PDE2A expression in embryonic DRGs and spinal cords. 
 
A) In situ hybridization of transverse sections of the spinal cord and DRGs with a PDE2A 
sense (S) or antisense (AS) probe reveals expression of PDE2A in DRGs and a ventrally 
localized pool of cells of the spinal cord. Scale bar, 200 µm. B) Immunostaining of transverse 
sections of the spinal cord and DRGs showing expression of PDE2A protein in DRGs, dorsal 
funiculus and a ventrally localized group of cells of the spinal cord. Scale bar, 200 µm. C) 
RT-PCR detection of PDE2A isoforms expressed in embryonic DRGs and spinal cord (SC). – 
no template in the reaction mixture, + amplification from an embryonic mouse cDNA library. 
TV, transcript variant; IF, isoform. D) Scheme of the different isoforms of PDE2A. E and F) 
for comparison, ISH of cGKI anti-sense probe and immunostaining of cGKI is shown. Scale 
bar, 200 µm. Broken lines in E) indicate the margin of the spinal cord and the DRG. G) 
Higher magnification of sections from an Npr2
LacZ/+
 reporter mouse indicates expression of 
PDE2A in Npr2-positive DRG neurons with nuclear labelling by an antibody to β-
galactosidase. Scale bar, 10 µm. 
 
Figure 6 
 
Analysis of sensory axon bifurcation in PDE2A mutant mice by DiI tracing. 
 
A) Transversal sections of embryonic spinal cord stained with antibodies to neurofilament 
(NF-M) indicate that the overall structure of PDE2A-deficient spinal cord is indistinguishable 
from wild type spinal cord. Scale bar, 100 µm. B) DiI tracing shows that bifurcation of 
sensory axons is not impaired in the absence of PDE2A. 402 and 317 DRG axons were 
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counted for wild type and for PDE2A -/-, respectively. In the right panel several PDE2A-
deficient bifurcating sensory axons were labeled by DiI that are located behind the front axon.  
T-test indicates that the percentage of bifurcating axons in the wild type and PDE2A -/- are 
indistinguishable (wild type n = 3, PDE2A -/- n = 3, p = 0.123). Scale bar, 25 µm. C) Scheme 
of T-branching of sensory axons in the spinal cord. Sensory axons enter the spinal cord at the 
so-called dorsal root entry zone, bifurcate (indicated by an A) and extend at the lateral margin 
of the spinal cord over several segments. At more advanced stages, these stem axons form 
collaterals (indicated by a B) that grow to dorsal or ventral target regions of the cord where 
terminal branching occurs (indicated by a C). 
 
 
Figure 7 
 
Localization of Npr3 in the spinal cord and analysis of its role in axon bifurcation. 
 
A) In situ hybridization using antisense (AS) and sense (S) probes to monitor Npr3 
expression in transversal sections of the spinal cord reveal localization of Npr3 mRNA in the 
floor plate (FP), roof plate (RP) and dorsal root (DR) but not in DRGs itself. Broken lines 
indicate the margin of the spinal cord and the DRG. B) Expression of alkaline phosphatase 
(AP) or a fusion protein composed of CNP-53 and alkaline phosphatase (AP-CNP-53) in 
transiently tranfected COS7 cells followed by Western blotting of the resultant conditioned 
media using antibodies to the alkaline phosphatase (upper panel, Rb-a-AP) or to CNP (lower 
panel, Rb-a-CNP). The left and right lanes show expression of the alkaline phosphatase or of 
the fusion protein, respectively. Molecular mass standards are indicated at the right of the 
panels. 
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C) Detection CNP receptors in a whole-mount preparation of embryonic spinal cord using a 
fusion protein of CNP-53 and alkaline phosphatase (AP-CNP-53). Dorsal views demonstrate 
binding in dorsal roots (DR) and the roof plate (RP) of wild type embryos (upper panel), but 
not or only very weakly in the corresponding structures of Npr3-deficient embryos (lower 
panel). No staining was observed in controls with alkaline phosphatase alone (not shown). (D 
and E) Analysis of axon bifurcation in Npr3 knockouts crossed to the reporter mouse Thy-1-
GFP-M. Spinal cords with attached DRGs were prepared at postnatal day 30 (P30). No 
ectopic bifurcation outside the DREZ were detected in the absence of Npr3. Arrows indicate 
bifurcations, arrow heads show turns in rostral or caudal directions and demonstrate the 
absence of bifurcations. In total 754 and 982 DRG axons were counted for wild type and 
Npr3-/- mutants, respectively. T-test indicates that wild type and Npr3 -/- are significantly 
distinct from each other (wild type n = 3, Npr3 -/- n = 8, p<0.001). 
European Journal of Neuroscience
For Peer Review
  
 
 
Fig. 1: 
 
FRET-based cGMP imaging in individual DRG neurons from R26-CAG-cGi500 (L1) mice.  
 
(A) Representative image of an E12.5 DRG growth cone expressing the cGMP sensor cGi500 (shown in 
green). A DRG explant culture was prepared to test the CNP stimulus on DRG growth cones. DRGs from 
R26-CAG-cGi500(L1) were isolated (see materials and methods), cut in half and transferred to the culture 
dish. Scale bar 10 µm. (B) Measurements were started 24 h after plating. FRET-based cGMP imaging was 
performed with perfusion of 100 nM CNP (black horizontal bar). Signals were recorded from the growth 
cone. Traces indicate CFP emission (F480), YFP emission (F535), and the CFP/YFP emission ratio 
(R=F480/F535). Emission intensities and ratios were normalized to averaged baseline signals and are given 
as ∆F/F and ∆R/R, respectively. (C) Expression of the cGi500 biosensor in a DRG neuron cultivated in a 
monolayer  from E12.5 embryos 24 hours after plating. Scale bar, 20 µm. (D) FRET-based cGMP imaging 
European Journal of Neuroscience
was performed with perfusion of drugs (horizontal bars) in the following order: 100 nM DEA/NO, 100 nM 
ANP, 100 nM BNP, and 100 nM CNP. Signals were recorded from the soma. Traces indicate CFP emission 
(F480), YFP emission (F535), and the CFP/YFP emission ratio (R=F480/F535). Emission intensities and ratios 
were normalized to averaged baseline signals and are given as ∆F/F and ∆R/R, respectively. Note that 
changes of ∆R/R indicate changes of the intracellular cGMP concentration. Based on in-cell calibration of 
cGi500 in permeabilized vascular smooth muscle cells (Thunemann et al. 2013a), the peak of the CNP-
induced cGMP transient in E12.5 DRG neurons corresponds to ~0.5 µM cGMP. Representative results from ≥ 
3 experiments with independent cell cultures are shown. 
(E-G) The broad-spectrum PDE inhibitor IBMX potentiates the CNP-induced cGMP signal in DRG neurons. (E 
and F) FRET-based cGMP imaging was performed in cells that were superfused three times with 100 nM CNP 
(black horizontal bars in panel F), with the second CNP application in presence of 100 µM IBMX (red 
horizontal bar in panel F). Signals were recorded from the soma. Changes of ∆R/R reflect changes of the 
intracellular cGMP concentration. The signals at time points t0-t3 indicated in panel F correspond to the 
pictures shown in panel E. (F) Compared to baseline (t0), stimulation with 100 nM CNP (t1) leads to an 
elevation of the CFP/YFP emission ratio (R=F480/F535) that correlates with the intracellular cGMP 
concentration. After preincubation with IBMX, CNP stimulation (t2) results in ~2.5 times higher peak cGMP 
concentrations as compared to CNP alone. After washout of IBMX, the third CNP application (t3) leads to an 
increase of the cGMP concentration that is comparable to the first stimulation. Scale bar, 20 µm. (G) 
Summary of CNP-induced cGMP signals before, during and after incubation with IBMX. Peak areas were 
taken as a measure of the cGMP response and normalized to the first peak of the experiment. Data are 
mean±SEM (n = 6 cells); ***p˂0.001.  
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       Fig. 2: Several PDEs are expressed in embryonic DRGs and spinal cord. (A and B) RT-PCR 
screen of cGMP-specific and dual substrate-specific PDEs expressed in E12.5 DRGs or spinal cord (SC). For 
comparison amplification products of Npr2 and cGKIα are shown in A). The sizes of the PCR amplification 
products are given in parenthesis. – no template in the reaction mixture, + amplification from an embryonic 
mouse cDNA library.  
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       Fig. 3: Pharmacological profiling of PDE activities in DRG neurons. FRET-based cGMP imaging 
was used to determine the effects of various PDE inhibitors on CNP-induced cGMP signals as described in the 
legend to Figure 1. Cells were stimulated three times with 100 nM CNP. The second CNP stimulation was 
done after preincubation of the cells for 5 min with (A) 5µM vinpocetine (Vin), (B) 10 nM Bay 60-7550 
(Bay), (C) 10 µM EHNA, 10 µM milrinone (Mil), (E) 20 µM sildenafil (Sil), or (F) 20 µM zaprinast (Zap). The 
specificity of each PDE inhibitor is indicated above each diagram. Signals were recorded from the soma. 
Peak areas were taken as a measure of the cGMP response and normalized to the first peak of each 
experiment. Data are mean±SEM (n cells in the experiment as indicated in the respective panel at the 
right); ***p˂0.001; *p˂0.05.  
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   Fig. 4: PDE2A degrades CNP-    induced cGMP. Intact DRGs from wild type, PDE2A heterozygote 
or homozygous knockout mice were incubated with or without CNP-22 (0.5 µM) for 15 minutes at 37oC in 
the presence or absence of IBMX (1 mM). The cGMP concentration in DRG extracts was determined by an 
ELISA-based method as described in (Schmidt et al. 2009).  Values are mean±SEM; numbers above 
columns indicate numbers of independent DRG preparations; t-tests were performed to compare the mean 
difference of two groups;*** p<0.001, n.s., non-significant.  
RevisedManuscript.docx  
60x46mm (300 x 300 DPI)  
 
 
European Journal of Neuroscience
For Peer Review
  
 
 
       Fig. 5: Analysis of PDE2A expression in embryonic DRGs and spinal cords. A) In situ 
hybridization of transverse sections of the spinal cord and DRGs with a PDE2A sense (S) or antisense (AS) 
probe reveals expression of PDE2A in DRGs and a ventrally localized pool of cells of the spinal cord. Scale 
bar, 200 µm. B) Immunostaining of transverse sections of the spinal cord and DRGs showing expression of 
PDE2A protein in DRGs, dorsal funiculus and a ventrally localized group of cells of the spinal cord. Scale bar, 
200 µm. C) RT-PCR detection of PDE2A isoforms expressed in embryonic DRGs and spinal cord (SC). – no 
template in the reaction mixture, + amplification from an embryonic mouse cDNA library. TV, transcript 
variant; IF, isoform. D) Scheme of the different isoforms of PDE2A. E and F) for comparison, ISH of cGKI 
anti-sense probe and immunostaining of cGKI is shown. Scale bar, 200 µm. Broken lines in E) indicate the 
margin of the spinal cord and the DRG. G) Higher magnification of sections from an Npr2LacZ/+ reporter 
mouse indicates expression of PDE2A in Npr2-positive DRG neurons with nuclear labelling by an antibody to 
β-galactosidase. Scale bar, 10 µm.  
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       Fig. 6: Analysis of sensory axon bifurcation in PDE2A mutant mice by DiI tracing. A) 
Transversal sections of embryonic spinal cord stained with antibodies to neurofilament (NF-M) indicate that 
the overall structure of PDE2A-deficient spinal cord is indistinguishable from wild type spinal cord. Scale bar, 
100 µm. B) DiI tracing shows that bifurcation of sensory axons is not impaired in the absence of PDE2A. 402 
and 317 DRG axons were counted for wild type and for PDE2A -/-, respectively. In the right panel several 
PDE2A-deficient bifurcating sensory axons were labeled by DiI that are located behind the front axon.  T-test 
indicates that the percentage of bifurcating axons in the wild type and PDE2A -/- are indistinguishable (wild 
type n = 3, PDE2A -/- n = 3, p = 0.123). Scale bar, 25 µm. C) Scheme of T-branching of sensory axons in 
the spinal cord. Sensory axons enter the spinal cord at the so-called dorsal root entry zone, bifurcate 
(indicated by an A) and extend at the lateral margin of the spinal cord over several segments. At more 
advanced stages, these stem axons form collaterals (indicated by a B) that grow to dorsal or ventral target 
regions of the cord where terminal branching occurs (indicated by a C).  
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       Fig. 7: Localization of Npr3 in the spinal cord and analysis of its role in axon bifurcation. A) In 
situ hybridization using antisense (AS) and sense (S) probes to monitor Npr3 expression in transversal 
sections of the spinal cord reveal localization of Npr3 mRNA in the floor plate (FP), roof plate (RP) and dorsal 
root (DR) but not in DRGs itself. Broken lines indicate the margin of the spinal cord and the DRG. B) 
Expression of alkaline phosphatase (AP) or a fusion protein composed of CNP-53 and alkaline phosphatase 
(AP-CNP-53) in transiently tranfected COS7 cells followed by Western blotting of the resultant conditioned 
media using antibodies to the alkaline phosphatase (upper panel, Rb-a-AP) or to CNP (lower panel, Rb-a-
CNP). The left and right lanes show expression of the alkaline phosphatase or of the fusion protein, 
 respectively. Molecular mass standards are indicated at the right of the panels. C) Detection CNP 
receptors in a whole-mount preparation of embryonic spinal cord using a fusion protein of CNP-53 and 
alkaline phosphatase (AP-CNP-53). Dorsal views demonstrate binding in dorsal roots (DR) and the roof plate 
(RP) of wild type embryos (upper panel), but not or only very weakly in the corresponding structures of 
Npr3-deficient embryos (lower panel). No staining was observed in controls with alkaline phosphatase alone 
(not shown). (D and E) Analysis of axon bifurcation in Npr3 knockouts crossed to the reporter mouse Thy-1-
GFP-M. Spinal cords with attached DRGs were prepared at postnatal day 30 (P30). No ectopic bifurcation 
outside the DREZ were detected in the absence of Npr3. Arrows indicate bifurcations, arrow heads show 
turns in rostral or caudal directions and demonstrate the absence of bifurcations. In total 754 and 982 DRG 
axons were counted for wild type and Npr3-/- mutants, respectively. T-test indicates that wild type and Npr3 
-/- are significantly distinct from each other (wild type n = 3, Npr3 -/- n = 8, p<0.001).  
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Table S1. Primer sequences to amplify CNP (Nppc), Npr2, Npr3, cGKI (Prkg1) or PDE 
sequences from mouse tissues. TV – transcript variants, IF – isoform  
 
Mouse 
Gene 
GenBank 
Acc. no. 
Primer sequence Product 
size (bp) 
Nppc NM_010933 FOR: 5’- ACCATGCACCTCTCCCAG -3’ 
REV: 5’- AGTGCACAGAGCAGTTCCC -3’ 
427 
Npr2 NM_173788 FOR: 5’-TGGCGCCTTCCCCTCCTGACT-3’ 
REV: 5’- CTGGGCCTGTTCCTGGGTTCG -3’ 
510 
Npr3 (TV1-
TV2) 
NM_008728 
NM_001039181 
FOR: 5’- CATAGTGCGCTACATCCAAG -3’ 
REV: 5’- CACAGAGAAGTCCCCATACC -3’ 
517 
Pde1a NM_016744 FOR: 5’- TCTGTACAACGACCGCTCAG -3’ 
REV: 5’- TTGCCCCGTAGTTTGAAGAC -3’ 
533 
Pde1b NM_008800 FOR: 5’- CCACCCAACTAAGCAGTGGT -3’ 
REV: 5’- TGGTTGTGCTCATCTTCTGC -3’ 
477 
Pde1c NM_011054 FOR: 5’- TTGACGAAAGCTCCCAGACT -3’ 
REV: 5’- TTCAAGTCACCGTTCTGCTG -3’ 
454 
Pde2a 
(TV1-TV5) 
 FOR: 5’- ATCCTGAACATCCCAGATGC -3’ 
REV: 5’- GATCCCGGTAGCCTTTCTTC -3’ 
535 
Pde2a 
(TV1; IF6) 
NM_001143848 FOR: 5’- GGAGATTTCCCGACTTCCAG -3’ 
REV: 5’- ACACCAATGACCTCCTGGTT -3’ 
500 
Pde2a (TV2; 
Pde2a3) 
NM_001008548 FOR: 5’- CGGCAGCGCGACCGGCTGAG -3’ 
REV: 5’- TCATCTGTGAAGAAATCTCC -3’ 
1018 
Pde2a (TV3; 
Pde2a2 and 
NM_001143849 
NM_001243757  
FOR: 5’- GTCCTGGTGTTGCACCACAT -3’ 
REV: 5’- GCAAGCTCTGTTCCTCACTG -3’ 
502 
(Pde2a2) 
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TV4, 
Pde2a1) 
564 
(Pde2a1) 
Pde2a (TV4; 
Pde2a1) 
NM_001243757 FOR: 5’- CTTGCACAGAAGCCAGAACC -3’ 
REV: 5’- TGATCTTCAGAGGCATCCACT -3’ 
542 
Pde2a 
(TV5; IF5) 
NM_001243758 FOR: 5’- TAGCCTTAGGAACCCAGTGC -3’ 
REV: 5’- TGCTTCTCTACCACCTGCAA -3’ 
513 
Pde3a NM_018779 FOR: 5’- TGTCCCGGCCAGAGTATAAC -3’ 
REV: 5’- CTTTCACAGGCTTCGTCCTC -3’ 
538 
Pde3b NM_011055 FOR: 5’- GCAAAAGATCGGGACCTACA -3’ 
REV: 5’- ATCCACCTGCAGTTTGTTCC -3’ 
471 
 
Pde5a NM_153422 FOR: 5’- AAACATGGGACACGTGAACA -3’ 
REV: 5’- CGCTGTTTCCAGATCAGACA -3’ 
403 
 
Pde6a NM_146086 FOR: 5’- TAAGCAAAGGCTACCGGAGA -3’ 
REV: 5’- TCTGTACCTCCCAGGGTTTG -3’ 
549 
Pde6b NM_008806 FOR: 5’- TGCTGACTGTGAGGAGGATG -3’ 
REV: 5’- CCAGAATTGAGGAGCCATGT -3’ 
446 
Pde6c NM_033614 FOR: 5’- GAAAGGGTACCGTCCTGTCA -3’ 
REV: 5’- CATCTGCTCGCAGGTATCAA -3’ 
424 
Pde6d NM_008801 FOR: 5’- GACCTGTCTGTCCCTGGTGT -3’ 
REV: 5’- AGCCTCACTTTGGATGTGCT -3’ 
332 
Pde6g NM_012065 FOR: 5’- CAAGGGTGAGATTCGGTCAG -3’ 
REV: 5’- CGTGCAGCTCTAGGTGATTG -3’ 
221 
Pde6h NM_023898 FOR: 5’- ACTTACGGGAACACATTCGG -3’ 
REV: 5’- CATGGGTCAGGGCCATATAC -3’ 
457 
Pde9a (TV1) NM_008804 FOR: 5’- GACGATGCCATGAAGGAGTT -3’ 447 
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or (TV2) NM_001163748 REV: 5’- ATTCATCCAAGGGGAAAACC -3’ 444 
Pde10a NM_011866 FOR: 5’- TCCATTGAGAAAGGGATTGC -3’ 
REV: 5’- TCAAAACAGGATGTCCCACA -3’ 
509 
Pde11a NM_001081033 FOR: 5’- GACCGAGGTGGAAATTTTAGC -3’ 
REV: 5’- CTTGTTCAAAGAACTCGCTGG -3’ 
458 
Prkg1  
(α-variant) 
NM_001013833 FOR: 5’- AAAAATGAGCGAACTGGAG -3’ 
REV: 5’- GACCTCTCGGATTTAGTGAAC -3’ 
273 
Prkg1 (α- 
and  
β-variant) 
NM_001013833 
NM_011160 
FOR: 5’- 
TCGGGGAGCTGGCTATACTTTACA -3’ 
REV: 5’- CTTCGGCTTCATATTTTGCTTTTG 
-3’ 
549 
AP-CNP-53  
 
T3 
 FOR: 
5’- GGGCTCGAGGACCTGCGTGTGGACACC 
-3’ 
REV: 5’- AATTAACCCTCACTAAAGGG -3’ 
287   
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Table S2. Statistics of FRET measurements as shown in Figure S2. 
 
 n number 
df 
(numerator + 
denominator) 
F statistics 
(Levene’s test) 
P value 
(Bonferroni test) 
Vinpocetine  10 29 1,26032 
CNP1/CNP2: 0,47939 
CNP2/CNP3: 1 
CNP1/CNP3: 1 
Bay60-7550 7 20 1,01815 
CNP1/CNP2: 4,30507E-7 
CNP2/CNP3: 7,06307E-7 
CNP1/CNP3: 1 
EHNA 3 8 7,16915 
CNP1/CNP2: 0,51305 
CNP2/CNP3: 0,72658 
CNP1/CNP3: 1 
Milrinone 8 23 0,19115 
CNP1/CNP2: 1 
CNP2/CNP3: 1 
CNP1/CNP3: 1 
Sildenafil 12 35 0,15948 
CNP1/CNP2: 1 
CNP2/CNP3: 1 
CNP1/CNP3: 1 
Zaprinast 9 26 2,38858 
CNP1/CNP2: 1 
CNP2/CNP3: 1 
CNP1/CNP3: 0,97735 
IBMX 6 17 1,0056 
CNP1/CNP2: 3,28141E-6 
CNP2/CNP3: 1,00787E-6 
CNP1/CNP3: 1 
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Fig. S1:   Single traces of FRET measurements using different PDE inhibitors. DRG neurons were superfused 
three times with 100 nM CNP (black horizontal bars), with the second CNP application in the presence of a PDE 
inhibitor (red horizontal bar) given at the indicated concentration. Signals were recorded from the soma. Changes 
of ΔR/R reflect changes of the intracellular cGMP concentration. Preincubation with PDE inhibitors before the 
application of CNP did not affect the cGMP levels.
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Fig. S2:   Pharmacological profiling of PDE activities in DRG neurons. Non-normalized values of Figure 3 (main 
text) are shown. The statistical analysis is summarized in table S2 of the supporting information. Cells were stimu-
lated three times with 100 nM CNP. The second CNP stimulation was done after preincubation of the cells with (A) 
5µM vinpocetine (Vin), (B) 10 nM Bay 60-7550 (Bay), (C) 10 µM EHNA, 10 µM milrinone (Mil), (E) 20 µM sildenafil 
(Sil), or (F) 20 µM zaprinast (Zap). The specificity of each PDE inhibitor is indicated above each diagram. Signals 
were recorded from the soma. Peak areas were taken as a measure of the cGMP. Data are mean±SEM;*** 
p<0.001; n.s., non- significant.
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Fig. S3:   Intact DRGs from wild type, PDE2A heterozygote or homozygous knockout mice were incubated with or 
without CNP-22 (0.5 µM) for 15 minutes at 37oC. The cGMP concentration in DRG extracts was determined by 
an ELISA-based method as described in (Schmidt et al. 2009).  Bars indicate SEM; numbers above columns 
indicate numbers of independent DRG preparations; t-tests were performed to compare the mean difference of 
two groups. n.s., non-significant.
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Fig. S4:   Analysis of AP-CNP-53 binding to heterologous cells. (A) Western blotting demonstrating detection of 
AP-CNP-53 in the supernatants of transiently transfected COS7 cells which was used for binding to Npr3 
expressed in COS7 cells (D) or in whole mounts of spinal cord (see Figure 7C). The vector encoding alkaline 
phosphatase or untransfected COS7 cells served as control. Equal protein loading is demonstrated by Ponceau 
staining. Rabbit antibodies to the alkaline phosphatase (GenHunter Corp, Q301) were used at a dilution of 1: 2500 
and rabbit antibodies to CNP22 (Peninsula Lab. Inc, T-4223) were applied at a dilution 1:2000. Goat anti-rabbit 
alkaline phosphatase (Dianova, 1:4000) and donkey guinea pig (Dianova, 1:4000) were used as secondary 
antibodies. (B) Western blotting demonstrating expression of mouse Npr2 in transfected COS7 cells. Equal prote-
in loading is demonstrated by Ponceau staining. Guinea pig antibodies to mNpr2 have been described elsewhere 
and were used at a dilution of 1:5000 (Ter-Avetisyan et al. 2014). Molecular mass markers are to the left of each 
panel. (C) Western blotting demonstrating expression of human Npr3 in tranfected COS7 cells. Equal protein 
loading is demonstrated by Ponceau staining. Rabbit antibodies to Npr3 were from Abcam (ab37617) and diluted 
at 1 µg/ml. Molecular mass markers are to the left of each panel. (D) Binding of AP-CNP-53 (pAPtag5[mCNP53C]) 
to COS7 cells transiently transfected with plasmids encoding Npr2 or Npr3. Strong binding is observed to Npr3 
whereas no signals above background were detected in Npr2 expressing cells. Specificity is demonstrated by 
applying the alkaline phosphatase alone (pAPtag5). The fusion protein AP-CNP-53 and the alkaline phosphatase 
were collected from COS7 supernatants (see A) and diluted 1:4 in medium.
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Expression of phosphodiesterase 2A in embryonic DRG neurons and localization of Npr3 in 
the dorsal roots, the roof plate and lining the floor plate is shown. Their influence on 
intracellular cGMP levels and their role in axon bifurcation of DRG neurons in PDE2A or 
Npr3 mutants was analyzed. 
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